Open access
Open access
Powered by Google Translator Translator

Tropical Medicine

WHO approves first ever malaria vaccine for children at risk.

7 Oct, 2021 | 10:40h | UTC

WHO recommends groundbreaking malaria vaccine for children at risk – World Health Organization

Commentaries:

WHO Approves First Ever Malaria Vaccine – Health Policy Watch

A historic day for malaria – reaction to WHO decision on the RTS,S vaccine – London School of Hygiene & Tropical Medicine

In major decision, WHO recommends broad rollout of world’s first malaria vaccine – STAT

Why the WHO approval of the first malaria vaccine is a big deal – Vox

WHO greenlights the world’s first malaria vaccine — but it’s not a perfect shot – NPR

The World Health Organization Just Endorsed The World’s First Malaria Vaccine – TIME

WHO Backs Widespread Use Of First Malaria Vaccine – Forbes

World’s 1st malaria vaccine recommended by WHO – LiveScience

 

Commentaries on Twitter

(thread – click for more)

 


Systematic Review: Administration of antimalarial drugs to whole populations for reducing malaria.

7 Oct, 2021 | 10:36h | UTC

Administration of antimalarial drugs to whole populations for reducing malaria – Cochrane Library

Original study: Mass drug administration for malaria – Cochrane Library

 

Commentary on Twitter

 


Drug-resistant malaria is gaining a foothold in Africa – “Analyses of patient blood samples suggest artemisinin effectiveness is slipping”.

28 Sep, 2021 | 08:49h | UTC

Drug-resistant malaria is gaining a foothold in Africa – Science

 

Commentary on Twitter

 


How COVID is derailing the fight against HIV, TB and malaria.

15 Sep, 2021 | 09:01h | UTC

How COVID is derailing the fight against HIV, TB and malaria – Nature

Related:

How COVID hurt the fight against other dangerous diseases

World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

 


An update on prevention of malaria in travelers.

15 Sep, 2021 | 08:39h | UTC

An update on prevention of malaria in travelers – Therapeutic Advances in Infectious Disease

Related: CDC Yellow Book

 


RCT: Severe malaria among young African children dramatically reduced through seasonal vaccination and preventative drug combination.

1 Sep, 2021 | 09:02h | UTC

News release: Severe malaria among young African children dramatically reduced through seasonal vaccination and preventative drug combination – London School of Hygiene & Tropical Medicine

Original article: Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention – New England Journal of Medicine

Commentary: Malaria trial shows ‘striking’ 70% reduction in severe illness in children – The Guardian

Related: Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

 


Cluster RCT: Vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh conferred 85% total protection.

11 Aug, 2021 | 08:28h | UTC

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial – The Lancet

Invited commentary: Salmonella Typhi Vi polysaccharide conjugate vaccine protects infants and children against typhoid fever – The Lancet

 


Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

15 Jul, 2021 | 09:02h | UTC

Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature – PLOS Neglected Tropical Diseases

 


CDC advisory panel backs use of dengue vaccine in high-risk areas, despite delivery challenges.

25 Jun, 2021 | 10:13h | UTC

CDC advisory panel backs use of dengue vaccine in high-risk areas, despite delivery challenges – STAT

 


WHO issues new guidance for research on genetically modified mosquitoes to fight malaria and other vector-borne diseases.

10 Jun, 2021 | 09:38h | UTC

News release: WHO issues new guidance for research on genetically modified mosquitoes to fight malaria and other vector-borne diseases – World Health Organization

Guideline: The guidance framework for testing genetically modified mosquitoes – World Health Organization

 


Cluster-randomized trial: Wolbachia-infected Aedes aegypti (less susceptible than wild-type A. aegypti to dengue virus infection) deployments reduced the incidence of symptomatic dengue and resulted in fewer hospitalizations.

10 Jun, 2021 | 09:40h | UTC

Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue – New England Journal of Medicine

Commentary: ‘Miraculous’ mosquito hack cuts dengue by 77% – BBC

Video Abstract: Efficacy of Wolbachia-infected Mosquito Deployments for the Control of Dengue

 


Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

25 Apr, 2021 | 21:17h | UTC

News release: Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal – University of Oxford

Original study (preprint): High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso – The Lancet

Commentaries: Malaria vaccine hailed as potential breakthrough – BBC AND Oxford Malaria vaccine proves highly effective in Burkina Faso trial – The Guardian

 

Commentary on Twitter (thread – click for more)

 


Ahead of World Malaria Day, WHO launches effort to stamp out malaria in 25 more countries by 2025

22 Apr, 2021 | 08:23h | UTC

World Malaria Day: WHO launches effort to stamp out malaria in 25 more countries by 2025 – World Health Organization

Report: Zeroing in on malaria elimination: Final report of the E-2020 initiative – World Health Organization

 


How COVID hurt the fight against other dangerous diseases

22 Apr, 2021 | 08:35h | UTC

How COVID hurt the fight against other dangerous diseases – Nature

Related: World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis AND WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

 


RCT: New shorter regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease

8 Apr, 2021 | 08:47h | UTC

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial – The Lancet Infectious Diseases

Commentary: Chagas disease: Shorter treatment just as effective as longer one, according to study in Bolivia published by The Lancet – Drugs for Neglected Diseases Initiative

 


Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease

5 Apr, 2021 | 01:05h | UTC

Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease – New England Journal of Medicine

Related: Resurgence of Ebola Virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days

 

Commentary on Twitter

 


Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature

31 Mar, 2021 | 03:01h | UTC

Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature – PLOS Neglected Tropical Diseases

 


Resurgence of Ebola Virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days

14 Mar, 2021 | 20:15h | UTC

Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days – Clinical Infectious Diseases

Commentaries: Bombshell analysis traces new Ebola outbreak to survivor of West Africa crisis – STAT AND New Ebola outbreak likely sparked by a person infected 5 years ago – Science AND Ebola survivors can pass on the virus: we’re trying to understand what role sex plays – The Conversation AND The latest Ebola outbreak may have started with someone infected years ago – Science News

 


WHO Guidance: Management of people affected by lymphatic filariasis

7 Mar, 2021 | 19:26h | UTC

News release: WHO publishes materials that aim to provide high-quality care to people affected by lymphatic filariasis – World Health Organization

Guidance: Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, 2nd ed. – World Health Organization

 


Systematic review: Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria

5 Mar, 2021 | 08:13h | UTC

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria – Cochrane Library

Summary: What are the benefits and risks of atovaquone-proguanil for treating uncomplicated malaria caused by the parasite? – Cochrane Library

 


Targeted spraying to prevent malaria in low-transmission setting halves cost of current practice

28 Feb, 2021 | 21:25h | UTC

News release: Targeted spraying to prevent malaria in low-transmission setting halves cost of current practice – Wits University

Original study: Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa – The Lancet

 

Commentary on Twitter

 


Turning houses into ‘lethal mosquito lures’ nearly halves incidence of malaria in children

28 Feb, 2021 | 21:26h | UTC

News release: Turning houses into ‘lethal mosquito lures’ nearly halves incidence of malaria in children – London School of Hygiene & Tropical Medicine

Original Study: Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d’Ivoire: a two-arm, cluster-randomised controlled trial – The Lancet

 

Commentary on Twitter (thread – click for more)

 


Clinical Update: Enteric Fever

28 Feb, 2021 | 21:02h | UTC

Enteric fever – The BMJ (free for a limited period)

 

Commentary on Twitter

 


M-A: Risk predictors of progression to severe disease during the febrile phase of dengue

28 Feb, 2021 | 20:57h | UTC

Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis – The Lancet Infectious Diseases

 


Global guideline for the diagnosis and management of rare mold infections

19 Feb, 2021 | 02:18h | UTC

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology – The Lancet Infectious Diseases (free for a limited period)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.